We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00662480
Recruitment Status : Recruiting
First Posted : April 21, 2008
Last Update Posted : February 25, 2016
Aarhus University Hospital
Information provided by:
Central Jutland Regional Hospital

Brief Summary:

Well-documented health benefits may be achieved through prophylactic screening for cardiovascular disease. The advantages are fewer premature deaths and a reduction in the number of hospital admissions and amputations. Furthermore, hospitals will benefit from the derived reduction in the pressure on surgery and intensive care capacities at vascular surgery departments.

It therefore seems extremely relevant to offer joint screening for abdominal aortic aneurysm, peripheral arterial disease and hypertension, even if the benefit and costs of such a measure are not currently known.

Consequently, the primary objective of the study is to establish the effect and cost-efficiency of a joint circulation screening programme for 40,000 men aged 65-74 years in a randomised, clinically controlled study.

The project manager will train six nurses to measure ABI and perform ultrasound scans of the aorta. The nurses form three teams which will each be equipped with a portable Doppler, blood pressure cuff and portable ultrasound scanner. Each team will operate from the hospitals in the Region. Civil registration number (in Danish: CPR), name and address information will be supplied by the Clinical Epidemiological Department (CED), which will also perform the randomisation in groups of approx. 1,000 to avoid too long a period from data extraction to invitation. Half of the randomised subjects will be invited to participate in a circulation examination focused on PAD, AAA and hypertension, while the other half will be controls Men with positive findings are informed and proper preventive actions is taken. Annual controls are offered, and AAA exceeding 5.5 cm in diameter is offered operation.

The primary efficiency variables are death, cardiovascular death and AAA-death. The secondary efficiency variables are hospital services related to cardiovascular conditions and costs for such services in accordance with current DRG rates.

The entire population, the controls as well as the screening group, will be monitored for a period of 10 years. Information concerning deaths, including date of death, is obtained from the Civil Registration System, information on visits to outpatient clinics and hospital admissions caused by cardiovascular conditions including amputations is obtained from the National Patient Registry. From the Danish Causes of Death Registry information on cause of death is collected. The information is classified with regards to cause; AAA or cardiovascular. The cardiovascular interventions are identified in the vascular surgery database (Karbasen). Major follow-up is performed at 3, 5 and 10 years.

A steering and data validation group will be formed including the project manager and a representative from the Clinical Epidemiology Department. Furthermore, a vascular surgeon from each of the two affected departments in the region will participate.

Total mortality, cardiovascular and AAA-related mortality and initial cardiovascular hospital service are compared for the two groups using Cox proportional hazards-regression analysis which facilitates description of the risk ratio. The cost-efficiency calculation will be adjusted for quality of life.

Condition or disease Intervention/treatment Phase
Abdominal Aortic Aneurysms Peripheral Arterial Disease Hypertension Procedure: Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm Phase 4

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Screening
Official Title: Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark
Study Start Date : September 2008
Estimated Primary Completion Date : September 2018
Estimated Study Completion Date : December 2023

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Invited to screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm
Procedure: Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm
Invited to vascular screening
No Intervention: 2
Participants which are not offered vascular screening

Primary Outcome Measures :
  1. All cause mortality [ Time Frame: 3, 5, and 10 years ]

Secondary Outcome Measures :
  1. Cardiovascular events [ Time Frame: 3,5 and 10 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   65 Years to 74 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • men aged 65-74 years old living in the central region of Denmark

Exclusion Criteria:

  • men not aged 65-74 years
  • men aged 65-74 years old not living in the central region of Denmark

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00662480

Contact: Jes S. Lindholt, M.D., Ph.D. +45 89272447 Jes.S.Lindholt@Viborg.RM.DK
Contact: Eskild W. Henneberg, M.D., +45 89272445 Eskild.W.Henneberg@Viborg.RM.DK

Vascular Research Unit, Dept. of Vasc. Surgery, Viborg Hospital Recruiting
Viborg, Denmark, 8800
Principal Investigator: Jes S. Lindholt, M.D., Ph.D.         
Sponsors and Collaborators
Central Jutland Regional Hospital
Aarhus University Hospital
Principal Investigator: Jes S. Lindholt, M.D.,Ph.D. Vascular Research Unit, Viborg Hospital

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jes S. Lindholt, Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital
ClinicalTrials.gov Identifier: NCT00662480     History of Changes
Other Study ID Numbers: M-20080028
First Posted: April 21, 2008    Key Record Dates
Last Update Posted: February 25, 2016
Last Verified: February 2009

Keywords provided by Central Jutland Regional Hospital:
abdominal aortic aneurysms
peripheral arterial disease

Additional relevant MeSH terms:
Aortic Aneurysm
Peripheral Arterial Disease
Peripheral Vascular Diseases
Aortic Aneurysm, Abdominal
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases
Arterial Occlusive Diseases